ABOUT US

ABOUTSMTP

TECHNOLOGY

Our company

Founded in 2010, SMTP Technology mainly engages in R&D, production and sales of high-tech surgical medical equipment. All products have independent intellectual property rights. SMTP entered International market in 2016 and acquired multiple International certificates such as FDA and CE. The products currently launched on the market include three series: Ultrasonic Osteotomy Surgical System、Ultrasonic Surgical Aspirator System and Ultrasonic Surgical System.
SMTP was the only enterprise that participated in the completion of Chinese industry standards 《YY/T1601-2018 Ultrasonic Bone Tissue Surgery Equipment》, 《YY/T1853-2022 Ultrasonic Bone Tissue Surgery Equipment Cutters》 and 《YY/T 1750-2020 Ultrasonic Soft Tissue Cutting and Hemostasis Surgical Equipment》.
With the mission of " Creating Reliable Tools to Simplify Treatments ", SMTP is committed to serving doctors and patients all over the world and becoming a model of active medical devices!

Our History

2010

2011

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

Founding of SMTP Technology

Establishment of production base

The production base was awarded as “Zhangjiagang Free Trade Zone Science and Technology Park Demonstration Enterprise”, “Jiangsu Province High-level Innovation and Entrepreneurship Talent Program Enterprise” and “Gusu Innovation and Entrepreneurship Leadership Talent Program Project Enterprise”.

The ultrasonic osteotomy surgical system XD860A lemna with independent intellectual property right was launched in China, regarded as “21st century bone cutting tool”.
SMTP Technology obtained CE certification.
SMTP Technology participated in formulating the national industry standard “Y/T1601-2018 Ultrasonic surgical equipment for osseous tissue” and served as a member of the Committee “TC10/SC2 Medical Ultrasonic Equipment”

SMTP Technology received the “National Science and Technology Support Program” from Ministry of Science and Technology of the People´s Republic of China.
SMTP Technology received investment from Qiming Venture Partners, an internationally renowned venture capital firm.

Products entered international market for sales.

More than 100 users worldwide.
Product launch of the world’s first ultrasonic osteotomy surgical system olea XD880A which supports both open surgery and minimally invasive surgery under intervertebral endoscope. This launch marked a new era beginning for minimally invasive osteotomy surgery.

The second-generation ultrasonic osteotomy surgical system obtained FDA approval and officially entered the American market.
”Y/T1601-2018 Ultrasonic surgical equipment for osseous tissue”, in which SMTP Technology participated in its formulation, was officially announced and implemented.

The product Ultrasonic osteotomy surgical system olea XD880A formally entered the European market and reached 10 users.
SMTP Technology completed the formulation “YY/T 1750-2020 Ultrasonic surgical equipment for soft tissue excision and hemostasia” in 2019.

More than 400 users around the world.
SMTP Technology, as the only enterprise, participated in formulating the national industry standard “YY/T 1750-2020 Ultrasonic surgical equipment for soft tissue excision and hemostasia”.

SMTP Technology completed the third iteration of the product and launched a new generation of Ultrasonic Osteotomy Surgical System betula FD880A. With a surgical robot it completed the world’s first case of posterior wall resection and decompression surgery for ossification of the ligamentum flavum in conjunction.

Product launch of Ultrasonic Surgical System agile XD680A.
“YY/T 1750-2020 Ultrasonic surgical equipment for soft tissue excision and hemostasia”, in which SMTP Technology participated in its formulation, was officially announced and implemented.

Product launch of Ultrasonic Surgical System 5mmSeries Shears wing5™.
Product launch of Ultrasonic Osteotomy Surgical System FD880A Plus cedars™ and Ultrasonic Osteotomy Surgical System FD880A Pro sanders™.